Draft Core Skills Occupations List (CSOL) for Consultation

May 15, 2024

Share Now

News articles linked via MedicalJobsAustralia.com are the copyright of the respective media organisations providing them.

Analysis and commentary © 2025 Health and Medical Pty Ltd.

Related Articles

Health Workforce Update - April 2024

The latest Internet Vacancy Index (IVI) by Jobs and Skills Australia recorded 4% fewer health and medical job advertisements in April 2024 compared to March 2024, and 6% fewer job ads compared to a year ago. Declines were observed across all occupational categories. Despite the month-on-month and year-on-year declines, health sector job advertisements and vacancies continue at record levels. More details here.

Read More
Incentives and support for GPs and general practices in MM locations

This collection of Fact Sheets from the Department of Health and Aged Care was updated on Feb-24 and provides lists of current financial and other incentives, such as subsidised training and scholarships, available to Australian GPs and General Practices in various Modified Monash (MM) locations. The Fact Sheets contain links to funding organisations and their application portal. You can check your location’s corresponding MM classification using the workforce locator map.

Read More
Queensland Government: Rollout begins for Australian-first pharmacy pilot

This media statement by the QLD Government announces the beginning of an Australian-first pharmacy pilot in north Queensland. The pilot aims to improve access to healthcare by allowing participating community pharmacists to treat and prescribe medicines for a range of common health conditions. The pilot will expand across the state over the next 12 months and continue until June 2026. Pharmacists need to complete specific education and training to be eligible to participate.

Read More
Drug companies pay doctors over A$11 million a year for travel and education. Here’s which specialties received the most

A recent analysis of reports from major drug companies found drug companies paid more than A$33 million to doctors in the three years from late 2019 to late 2022 for consultancies and other expenses. Post-pandemic funding levels, particularly for travel, are expected to be even higher. Specialists, including rheumatologists and cancer doctors, received the most funding. Read more in this article by The Conversation, here.

Read More
All Blog Articles